Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alvin D Milner

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Haematologica|July 21, 2007
Patients with multiple myeloma treated with thalidomide: evaluation of clinical parameters, cytokines,angiogenic markers, mast cells and marrow CD57+ cytotoxic T cells as predictors of outcomeLinda Mileshkin, Dirk Honemann, Peter Gambell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2005
A multicenter phase II trial of thalidomide and celecoxib for patients with relapsed and refractory multiple myelomaH Miles Prince, Linda Mileshkin, Andrew Roberts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2006
Relationship of hepatic functional imaging to irinotecan pharmacokinetics and genetic parameters of drug eliminationMichael Michael, Mick Thompson, Rod J Hicks, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Haematologica|July 21, 2007
Patients with multiple myeloma treated with thalidomide: evaluation of clinical parameters, cytokines,angiogenic markers, mast cells and marrow CD57+ cytotoxic T cells as predictors of outcomeLinda Mileshkin, Dirk Honemann, Peter Gambell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2005
A multicenter phase II trial of thalidomide and celecoxib for patients with relapsed and refractory multiple myelomaH Miles Prince, Linda Mileshkin, Andrew Roberts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2006
Relationship of hepatic functional imaging to irinotecan pharmacokinetics and genetic parameters of drug eliminationMichael Michael, Mick Thompson, Rod J Hicks, et al.
Pageof 2